Bassetti M.; Giacobbe D.R.; Bruzzi P.; Barisione E.; Centanni S.; Castaldo N.; Corcione S.; De Rosa F.G.; Di Marco F.; Gori A.; Gramegna A.; Granata G.; Gratarola A.; Maraolo A.E.; Mikulska M.; Lombardi A.; Pea F.; Petrosillo N.; Radovanovic D.; Santus P.; Signori A.; Sozio E.; Tagliabue E.; Tascini C.; Vancheri C.; Vena A.; Viale P.; Blasi F., A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP), «INFECTIOUS DISEASES AND THERAPY», 2021, 1, pp. 1 - 1 [replica/breve intervento]Open Access
Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of bsis, cutis, and ciais caused by enterobacterales in critically ill adult patients, «INFECTION AND DRUG RESISTANCE», 2021, 14, pp. 2461 - 2498 [articolo]Open Access
Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2021, na, pp. 1 - 22 [articolo]
Gatti M.; Pea F., Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 1271 - 1289 [articolo]Open Access
Gatti M.; Cojutti P.G.; Pascale R.; Tonetti T.; Laici C.; Dell'olio A.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections, «ANTIBIOTICS», 2021, 10, Article number: 1311, pp. 1 - 12 [articolo]Open Access
Cojutti P.G.; Londero A.; Della Siega P.; Givone F.; Fabris M.; Biasizzo J.; Tascini C.; Pea F., Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6”, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 833 - 834 [articolo]
Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]Open Access
Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]Open Access
Falcone M.; De Angelis B.; Pea F.; Scalise A.; Stefani S.; Tasinato R.; Zanetti O.; Dalla Paola L., Challenges in the management of chronic wound infections, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2021, 26, pp. 140 - 147 [articolo]Open Access
Bassetti M.; Giacobbe D.R.; Bruzzi P.; Barisione E.; Centanni S.; Castaldo N.; Corcione S.; De Rosa F.G.; Di Marco F.; Gori A.; Gramegna A.; Granata G.; Gratarola A.; Maraolo A.E.; Mikulska M.; Lombardi A.; Pea F.; Petrosillo N.; Radovanovic D.; Santus P.; Signori A.; Sozio E.; Tagliabue E.; Tascini C.; Vancheri C.; Vena A.; Viale P.; Blasi F.; Bassetti M.; Giacobbe D.R.; De Rosa F.G.; Di Marco F., Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP), «INFECTIOUS DISEASES AND THERAPY», 2021, na, pp. 1 - 49 [articolo]Open Access
Gatti M.; De Ponti F.; Pea F., Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies, «CNS DRUGS», 2021, 35, pp. 345 - 384 [articolo]Open Access
Gatti, Milo; Pea, Federico, Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections, «CURRENT OPINION IN INFECTIOUS DISEASES», 2021, 34, pp. 737 - 747 [articolo]Open Access
Tiseo G.; Arena F.; Borre S.; Campanile F.; Falcone M.; Mussini C.; Pea F.; Sganga G.; Stefani S.; Venditti M., Diagnostic stewardship based on patient profiles: differential approaches in acute versus chronic infectious syndromes, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2021, 19, pp. 1373 - 1383 [articolo]Open Access
Cojutti P.G.; Gatti M.; Rinaldi M.; Tonetti T.; Laici C.; Mega C.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 781892, pp. 1 - 11 [articolo]Open Access
Roberto Cairoli; Felicetto Ferrara; Corrado Girmenia; Mario Luppi; Federico Pea; Giorgina Specchia; Adriano Venditti, Management of patients with acute myeloid leukemia undergoing therapy with midostaurin: a focus on antifungal prophylaxis, «HEMATOLOGICAL ONCOLOGY», 2021, 39, pp. 20 - 26 [articolo]
